Our pipeline
Advancing medicines.
Modernizing delivery.
We are developing medicines with RITe™, led by ORC-144, our investigational cannabidiol tablet for acute pain in adults.
Intended use
ORC-144
For the temporary relief of minor aches and pains
ORC-241
Relief of mild-to-moderate pain, reduction of fever, and management of inflammatory conditions
ORC-704
Smoking cessation and craving control
ORC-608
Erectile dysfunction
Orcosa’s product candidates are investigational and have not been approved by the FDA. Their safety and effectiveness for the uses under investigation have not been established.
ORC-144
Cannabidiol orally disintegrating tablet
Acute pain
A new approach to acute pain.
ORC-144 combines our proprietary cannabidiol formulation with the RITe™ platform in an easy-to-take tablet. We are advancing this investigational, non-opioid medicine to expand treatment options for people with acute pain, building on encouraging clinical results in pain control and patient satisfaction following rotator cuff repair.
Explore the science